211 related articles for article (PubMed ID: 17879836)
1. Epirubicin for breast cancer during pregnancy: a case report.
Eedarapalli P; Biswas N; Coleman M
J Reprod Med; 2007 Aug; 52(8):730-2. PubMed ID: 17879836
[TBL] [Abstract][Full Text] [Related]
2. Weekly epirubicin in the treatment of gestational breast cancer (GBC).
Peccatori FA; Azim HA; Scarfone G; Gadducci A; Bonazzi C; Gentilini O; Galimberti V; Intra M; Locatelli M; Acaia B; Rossi P; Cinieri S; Calabrese L; Goldhirsch A
Breast Cancer Res Treat; 2009 Jun; 115(3):591-4. PubMed ID: 18712595
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature.
Gadducci A; Cosio S; Fanucchi A; Nardini V; Roncella M; Conte PF; Genazzani AR
Anticancer Res; 2003; 23(6D):5225-9. PubMed ID: 14981994
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
[TBL] [Abstract][Full Text] [Related]
5. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
6. Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging.
Tsunoda-Shimizu H; Hayashi N; Hamaoka T; Kawasaki T; Tsugawa K; Yagata H; Kikuchi M; Suzuki K; Nakamura S
Breast Cancer; 2008; 15(2):133-40. PubMed ID: 18288570
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin as adjuvant therapy in breast cancer.
Earl H; Iddawela M
Expert Rev Anticancer Ther; 2004 Apr; 4(2):189-95. PubMed ID: 15056049
[TBL] [Abstract][Full Text] [Related]
8. [A case of locally advanced breast cancer successfully treated with intra-arterial infusion chemotherapy of high-dose epirubicin].
Kim Y; Takatsuka Y; Hasegawa S; Kondou M; Hirao T; Kan K; Fukunaga M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2119-22. PubMed ID: 9838916
[TBL] [Abstract][Full Text] [Related]
9. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
Sharma JB; Pushparaj M; Kumar S; Roy KK; Raina V; Malhotra N
Arch Gynecol Obstet; 2009 Mar; 279(3):415-7. PubMed ID: 18642013
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy during pregnancy: what is really safe?
Peccatori F; Martinelli G; Gentilini O; Goldhirsch A
Lancet Oncol; 2004 Jul; 5(7):398. PubMed ID: 15231245
[No Abstract] [Full Text] [Related]
11. Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer.
Hunz M; Jetter A; Warm M; Pantke E; Tuscher M; Hempel G; Jaehde U; Untch M; Kurbacher C; Fuhr U
Clin Pharmacol Ther; 2007 May; 81(5):659-68. PubMed ID: 17301739
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW
Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963
[TBL] [Abstract][Full Text] [Related]
13. [Breast cancer during pregnancy--a case report].
Matsunoki A; Yoshino H; Takayanagi T; Kadoya S; Kotake M; Ishiguro K; Kurokawa M; Morita K; Bandou H; Yamada C; Yamada T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):991-3. PubMed ID: 18633231
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review.
Isaacs RJ; Hunter W; Clark K
Gynecol Oncol; 2001 Mar; 80(3):405-8. PubMed ID: 11263941
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature.
Potluri V; Lewis D; Burton GV
Clin Breast Cancer; 2006 Jun; 7(2):167-70. PubMed ID: 16800979
[TBL] [Abstract][Full Text] [Related]
16. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
17. A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.
O'Connor R; O'Leary M; Ballot J; Collins CD; Kinsella P; Mager DE; Arnold RD; O'Driscoll L; Larkin A; Kennedy S; Fennelly D; Clynes M; Crown J
Cancer Chemother Pharmacol; 2007 Jan; 59(1):79-87. PubMed ID: 16642371
[TBL] [Abstract][Full Text] [Related]
18. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
[TBL] [Abstract][Full Text] [Related]
19. Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.
Zekri JM; El-Helw LM; Purohit OP; Hatton MQ; Coleman RE
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):513-6. PubMed ID: 18513930
[TBL] [Abstract][Full Text] [Related]
20. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report.
Lycette JL; Dul CL; Munar M; Belle D; Chui SY; Koop DR; Nichols CR
Clin Breast Cancer; 2006 Oct; 7(4):342-4. PubMed ID: 17092404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
